Danicamtiv, a Novel Cardiac Myosin Activator, Is Associated with Improved Right Ventricular Function: pre-clinical and clinical evidence in patients with DCM

30 August 2026 (08:15 - 08:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Basic & Translational Science Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology